by | Oct 25, 2010 | Towing
Tiny, little-known biotech Clinical Data has developed a potential blockbuster drug called Vilazodone. If OK’d, it would be the first new depression treatment in 15 years. Its potential is so huge that several Big Pharmas are s…
by | Oct 25, 2010 | Towing
BP (BP) will sell four deep-water oil and gas fields in the Gulf of Mexico for $650 million.
The company will sell the fields to Marubeni Oil and Gas, a unit of Japan’s Marubeni Corp., The Wall Street Journal said. The deal could be completed by early 2011.
Sponsored Links
The oil giant’s net production from these fields is about 15,000 barrels of oil equivalent a day. The fields “did not fit well…
Continue reading BP to Sell Four Oil Fields in Gulf of Mexico for $650 Million
BP to Sell Four Oil Fields in Gulf of Mexico for $650 Million originally appeared on DailyFinance on Mon, 25 Oct 2010 07:26:00.
Filed Under: Energy, Company News, Green, BP
by | Oct 25, 2010 | Towing
Gemalto NV, a Dutch maker of security software, sued Google (GOOG), saying that the Android smartphone operating system used its software without permission.
The complaint accuses Google of improperly including Gemalto’s Java Card technology in the Android development platform, Bloomberg News said.
Sponsored Links
Java Card allows software written in Java and other programming languages to work on…
Continue reading Gemalto Sues Google Over Android OS
Gemalto Sues Google Over Android OS originally appeared on DailyFinance on Mon, 25 Oct 2010 06:32:00.
Filed Under: Company News, Technology, Media, Google , Motorola, Samsung
by | Oct 24, 2010 | Towing
Dozens of companies report earnings this week, and analysts surveyed by Thomson Reuters are anticipating lots of strong quarterly reports. Among those posting improved results should be Microsoft and Visa. However, likely to p…
by | Oct 24, 2010 | Towing
This week, Barnes & Noble is expected to unveil a new, color edition of the Nook e-reader. As the company moves forward with new digital products, however, it faces lawsuits that won’t go away — and which have the potential to…